Appeals Court Reinstates More Than 100 Lawsuits Against Makers Of HRT Prempro
Main Category: Breast CancerAlso Included In: Litigation / Medical Malpractice; Women's Health / Gynecology; Menopause
Article Date: 11 Jan 2010 - 2:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4.67 (3 votes) |
The 8th U.S. Circuit Court of Appeals in St. Louis on Wednesday reinstated more than 100 lawsuits against pharmaceutical companies filed by women or their surviving relatives claiming that the companies' hormone replacement therapy drugs caused breast cancer, the AP/San Francisco Chronicle reports. The AP/Chronicle reports that the women -- whose ages ranged from their 30s to their 80s -- received the HRT drugs, such as the combination estrogen-progestin drug Prempro, to treat symptoms of menopause. There are several thousand similar lawsuits filed nationwide.
The appellate court's decision overturns a 2008 district court's dismissal of the cases that prevented them from being heard in state courts in Arkansas and Minnesota. The new decision also reinstates dozens of cases that the lower court dismissed because they reportedly duplicated claims that are pending in California. According to the AP/Chronicle, the plaintiffs argued that the district court judge failed to provide them with a "reasonable opportunity" to be heard. They also said that the judge abused his authority by rejecting a stay on the cases until the claims in California were resolved.
The suit names 12 drug companies. Among the manufactures of the HRT drugs named in the suits are Pfizer, Barr Laboratories, Mead Johnson and Wyeth, which Pfizer acquired last year. The companies maintain that customers now are fully informed about the risks and benefits linked with the therapies (Bartels, AP/San Francisco Chronicle, 1/7).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
Visit our breast cancer section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/175521.php>
APA
http://www.medicalnewstoday.com/releases/175521.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





